Moolec Science (MLECW) Invested Capital (2022 - 2025)
Moolec Science (MLECW) posted Invested Capital of $246.8 million for Q2 2025, up 1173.81% sequentially from $19.4 million in Q4 2024, and down 45.06% YoY from $449.1 million in Q2 2024.
Moolec Science (MLECW) Invested Capital (2022 - 2025) Analysis & Trends
Moolec Science has reported Invested Capital for 4 years, with the latest figure at $246.8 million in Q2 2025.
- Quarterly Invested Capital fell 45.06% year-over-year to $246.8 million in Q2 2025, while the trailing twelve-month figure through Mar 2026 was $266.1 million (changed N/A YoY) and the FY2025 annual result came in at $246.8 million, down 45.06% from the prior year.
- Invested Capital grew to $246.8 million in Q2 2025 per MLECW's latest filing, from $19.4 million in the prior quarter.
- Over five years, Invested Capital peaked at $449.1 million in Q2 2024 and troughed at $838117.0 in Q4 2022.
- A 4-year average of $128.5 million and a median of $18.2 million in 2024 frame the typical range for Invested Capital.
- The sharpest annual moves came in 2024 and 2025: Invested Capital jumped 802.51% in 2024, then slumped 45.06% in 2025.
- Over 4 years, Invested Capital stood at $838117.0 in 2022, then surged by 570.3% to $5.6 million in 2023, then surged by 244.83% to $19.4 million in 2024, then jumped by 1173.81% to $246.8 million in 2025.
- According to Business Quant data, Invested Capital over the past three periods registered $246.8 million, $19.4 million, and $18.2 million for Q2 2025, Q4 2024, and Q3 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 190.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.45 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 380.00 Mn |
| 10 | Moolec Science | 8,617.72 | -1.19 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 246.76 Mn |
| Dec 31, 2024 | 19.37 Mn |
| Sep 30, 2024 | 18.22 Mn |
| Jun 30, 2024 | 449.15 Mn |
| Mar 31, 2024 | 10.61 Mn |
| Dec 31, 2023 | 5.62 Mn |
| Sep 30, 2023 | 12.76 Mn |
| Jun 30, 2023 | 412.22 Mn |
| Mar 31, 2023 | 1.18 Mn |
| Dec 31, 2022 | 838,117.00 |
| Jun 30, 2022 | 236.31 Mn |